HD-OPM Archive
Topics › Brain health & dementia

Plasma p-tau217 predicts dementia: 3x per SD, 7x top vs bottom quartile in 2,766 women

Louis Nervegna · Apr 05, 2026 · ♥ 5 reactions · 6 comments · original Facebook post
Brain health & dementia
AI summary & key facts

A cohort of 2,766 women followed up to 25 years found each SD rise in p-tau217 tripled dementia risk and the top quartile had 7 times the risk of the bottom, with stronger effects in women over 70 and APOE4/4 carriers.

A single blood test taken today could tell you whether you're on a path toward Alzheimer's 25 years from now.

Researchers followed 2,766 women for up to a quarter of a century, tracking a biomarker called p-tau217: a protein that gets chemically tagged during the early stages of Alzheimer's disease, long before any symptoms appear.

Every standard deviation increase in p-tau217 was associated with a 3x increase in risk of developing dementia.

The highest quartile (top 25%) had 7x the risk of the lowest quartile (bottom 25%).

The relationship was stronger in women over 70 and in APOE4/4 carriers.

Women who already had elevated ptau217 were at an even higher risk of developing dementia if they were on HRT, specifically estrogen + progestin.

#ptau217HD #alzheimersHD #hrtHD #apoe4HD #dementiaHD #estrogenHD #progestinHD

Research cited

← newer: Glycine 5 g three times daily lowered A1C from 8.3 to 6.9 inolder: More protein without resistance training did not improve mus →